Delivery Order SPE2DR25D1201-SPE2DR26FAJNS
- Not listed
- The Defense Logistics Agency awarded a $12,773.08 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of 500 tablets of Ondansetron HCL 4 mg, with completion scheduled for June 3, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a routine pharmaceutical procurement from the government's primary pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,752.69 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500-count units) with an ultimate completion date of June 2, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a competitive award under the company's larger pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 MG, with a ceiling value of $13,338.54 under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside provisions and has an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,537.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) with an ultimate completion date of October 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $33,081.12 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $212,889.17 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 500 units. This firm fixed price, competitively awarded delivery order is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the vendor competed against other qualified...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 19, 2025, for 500 tablets of Ondansetron HCl 4 mg with a ceiling value of $49,896.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. This delivery order is...
- The Defense Logistics Agency awarded a $7,629.82 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ondansetron HCl 4 mg tablets (500 count) with a contract value of $8,155.72. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the federal government's primary pharmaceutical distributors and serves as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a $8,222.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (500 count) with completion targeted for September 25, 2025. This non-set-aside competitive award was issued on September 24, 2025, and represents pharmaceutical procurement for federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJNSDelivery Order
The Defense Logistics Agency awarded a $12,322.75 delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, with an ultimate completion date of October 24, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor based in Conshohocken, Pennsylvania. The pharmaceutical product will be delivered to the same location, supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As one of the major pharmaceutical distributors serving federal medical procurement needs, AmerisourceBergen has demonstrated capability to meet DLA requirements across multiple therapeutic domains through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 10/23/25 |